Article | January 20, 2023

The Commercial Manufacturing Checklist For Cell Therapy Developers

Source: Minaris Regenerative Medicine
GettyImages-879828000-lab-cell-microscope

Here's the question: “Is your business ready for commercially viable manufacturing of your patient-specific cell therapy?”

To help you answer this question, the Minaris Regenerative Medicine team has put together a checklist of items related to commercially viable manufacturing. This checklist is meant to provide a rough idea of where your process is on the path so you can start to make improvements.

This checklist does not constitute legal advice — it is merely meant to provide a quick and easy way to perform a rough self-assessment of your readiness for commercially-viable cell therapy manufacturing.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene